US Stock MarketDetailed Quotes

OSTX OS Therapies

Watchlist
  • 2.140
  • +0.080+3.88%
Close Nov 29 13:00 ET
  • 2.150
  • +0.010+0.47%
Post 14:32 ET
45.45MMarket Cap-6114P/E (TTM)

OS Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
20.71%-3.01M
-871.16K
-876.57K
-831.05K
55.44%-428.19K
13.86%-3.79M
-960.91K
Net income from continuing operations
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
---1.46M
---1.97M
---2.51M
-35.56%-1.85M
15.71%-6.25M
---1.36M
Depreciation and amortization
--0
-13.66%695
595.00%695
424.22%4.22K
--0
--3.32K
--805
--100
0.00%805
--0
Other non cash items
-67.09%322.92K
-46.58%446.53K
-21.03%578.74K
82.51%2.76M
--213.24K
--981.14K
--835.93K
194.20%732.84K
-38.00%1.51M
--249.09K
Change In working capital
-830.48%-832.48K
-72.64%229.07K
-65.32%237.83K
112.94%2.02M
--380.17K
--113.96K
--837.27K
349.68%685.84K
64.85%947.33K
--152.52K
-Change in payables and accrued expense
-799.77%-797.48K
-72.64%229.07K
-65.32%237.83K
112.94%2.02M
--380.17K
--113.96K
--837.27K
349.68%685.84K
64.85%947.33K
--152.52K
Cash from discontinued investing activities
Operating cash flow
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
20.71%-3.01M
---871.16K
---876.57K
---831.05K
55.44%-428.19K
13.86%-3.79M
---960.91K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-99.50%1.15K
19
0
-19
1.15K
15.17%230.88K
0
Net PPE purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net other investing changes
----
----
----
-99.50%1.15K
--0
--0
--0
--1.15K
8.70%230.88K
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
-99.50%1.15K
--19
--0
---19
--1.15K
15.17%230.88K
--0
Financing cash flow
Cash flow from continuing financing activities
510.38%5.15M
66.81%875.89K
15.10%702.98K
-21.33%2.87M
894.06K
843.41K
525.08K
-33.97%610.78K
19.74%3.65M
925K
Net issuance payments of debt
-130.30%-250K
84.62%900K
9.81%851K
-17.44%3.16M
--1.07M
--825K
--487.5K
-16.22%775K
29.63%3.82M
--925K
Net other financing activities
----
-164.17%-24.12K
9.87%-148.02K
-65.20%-284.18K
---175.94K
--18.41K
--37.58K
---164.23K
-272.02%-172.02K
----
Cash from discontinued financing activities
Financing cash flow
510.38%5.15M
66.81%875.89K
15.10%702.98K
-21.33%2.87M
--894.06K
--843.41K
--525.08K
-33.97%610.78K
19.74%3.65M
--925K
Net cash flow
Beginning cash position
92.85%94.93K
-71.78%100.23K
-77.27%38.98K
112.26%171.48K
--16.06K
--49.22K
--355.21K
112.26%171.48K
-93.45%80.79K
--80.79K
Current changes in cash
5,416.71%1.76M
98.27%-5.31K
-66.66%61.25K
-246.10%-132.5K
--22.92K
---33.16K
---305.99K
611.68%183.73K
107.87%90.69K
---35.91K
End cash Position
11,470.48%1.86M
92.85%94.93K
-71.78%100.23K
-77.27%38.98K
--38.98K
--16.06K
--49.22K
691.48%355.21K
112.26%171.48K
--44.88K
Free cash flow
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
20.71%-3.01M
---871.14K
---876.57K
---831.07K
55.44%-428.19K
14.09%-3.79M
---960.91K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -286.14%-3.38M-6.03%-881.19K-49.87%-641.73K20.71%-3.01M-871.16K-876.57K-831.05K55.44%-428.19K13.86%-3.79M-960.91K
Net income from continuing operations -45.58%-2.88M37.83%-1.56M21.01%-1.46M-24.57%-7.79M---1.46M---1.97M---2.51M-35.56%-1.85M15.71%-6.25M---1.36M
Depreciation and amortization --0-13.66%695595.00%695424.22%4.22K--0--3.32K--805--1000.00%805--0
Other non cash items -67.09%322.92K-46.58%446.53K-21.03%578.74K82.51%2.76M--213.24K--981.14K--835.93K194.20%732.84K-38.00%1.51M--249.09K
Change In working capital -830.48%-832.48K-72.64%229.07K-65.32%237.83K112.94%2.02M--380.17K--113.96K--837.27K349.68%685.84K64.85%947.33K--152.52K
-Change in payables and accrued expense -799.77%-797.48K-72.64%229.07K-65.32%237.83K112.94%2.02M--380.17K--113.96K--837.27K349.68%685.84K64.85%947.33K--152.52K
Cash from discontinued investing activities
Operating cash flow -286.14%-3.38M-6.03%-881.19K-49.87%-641.73K20.71%-3.01M---871.16K---876.57K---831.05K55.44%-428.19K13.86%-3.79M---960.91K
Investing cash flow
Cash flow from continuing investing activities 000-99.50%1.15K190-191.15K15.17%230.88K0
Net PPE purchase and sale --0------------------0----------------
Net other investing changes -------------99.50%1.15K--0--0--0--1.15K8.70%230.88K----
Cash from discontinued investing activities
Investing cash flow --0--0--0-99.50%1.15K--19--0---19--1.15K15.17%230.88K--0
Financing cash flow
Cash flow from continuing financing activities 510.38%5.15M66.81%875.89K15.10%702.98K-21.33%2.87M894.06K843.41K525.08K-33.97%610.78K19.74%3.65M925K
Net issuance payments of debt -130.30%-250K84.62%900K9.81%851K-17.44%3.16M--1.07M--825K--487.5K-16.22%775K29.63%3.82M--925K
Net other financing activities -----164.17%-24.12K9.87%-148.02K-65.20%-284.18K---175.94K--18.41K--37.58K---164.23K-272.02%-172.02K----
Cash from discontinued financing activities
Financing cash flow 510.38%5.15M66.81%875.89K15.10%702.98K-21.33%2.87M--894.06K--843.41K--525.08K-33.97%610.78K19.74%3.65M--925K
Net cash flow
Beginning cash position 92.85%94.93K-71.78%100.23K-77.27%38.98K112.26%171.48K--16.06K--49.22K--355.21K112.26%171.48K-93.45%80.79K--80.79K
Current changes in cash 5,416.71%1.76M98.27%-5.31K-66.66%61.25K-246.10%-132.5K--22.92K---33.16K---305.99K611.68%183.73K107.87%90.69K---35.91K
End cash Position 11,470.48%1.86M92.85%94.93K-71.78%100.23K-77.27%38.98K--38.98K--16.06K--49.22K691.48%355.21K112.26%171.48K--44.88K
Free cash flow -286.14%-3.38M-6.03%-881.19K-49.87%-641.73K20.71%-3.01M---871.14K---876.57K---831.07K55.44%-428.19K14.09%-3.79M---960.91K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+0.64%